340B Ceiling Prices Take Effect January 2019 / by AzHHA

Debbie Johnston, Senior Vice President of Policy Development

After several years being delayed, The Health and Human Services issued a final rule on its final regulations on drug ceiling prices and civil monetary penalties for manufacturers under the 340B Drug Pricing Program. The new policies will be effective January 1, 2019. In September several hospital systems and associations filed a lawsuit asking a federal court to order the Department of Health and Human Services to make effective within 30 days a final rule requiring drug companies to disclose the ceiling price for 340B outpatient drugs after HHS had delayed effective date for the rule five times.